Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Short stature, Decreased serum insulin-like growth factor 1, and Reduced circulating growth hormone concentration; and very common findings: Anterior pituitary hypoplasia. 15 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Hormones | 8 | Anterior pituitary hypoplasia, Anterior pituitary agenesis, Decreased serum insulin-like growth factor 1 |
ROBO1 function has not been fully characterized.
Pituitary hormone deficiency, combined or isolated, 8 is associated with mutations in the ROBO1 gene on chromosome 3.
Genetic testing for ROBO1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for pituitary hormone deficiency, combined or isolated, 8 has been reported in the published literature.
Phenotype severity distribution: 3 always present features, 1 very common feature, 5 common features.
No clinical trials have been registered for pituitary hormone deficiency, combined or isolated, 8.
202 publications have been identified in PubMed for pituitary hormone deficiency, combined or isolated, 8. Research spans Basic Science / Preclinical (41%), Clinical Trial Publication (16%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 71 | 41% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 1:02 AM UTC
Online Mendelian Inheritance in Man
Growth and development |
3 |
Short stature, Decreased serum insulin-like growth factor 1, Reduced circulating growth hormone concentration |
Eyes | 2 | Strabismus, Ptosis |
Lab test results | 2 | Decreased circulating luteinizing hormone level, Decreased thyroid-stimulating hormone level |
Clinical study results |
28 |
16% |
Disease patterns and progression | 28 | 16% |
Patient case studies | 18 | 10% |
Research summaries | 13 | 7% |
Testing and diagnosis research | 11 | 6% |
New treatment approaches | 5 | 3% |
Karachaliou F (2026). [PMID: 40684755](https://pubmed.ncbi.nlm.nih.gov/40684755/). *Horm Res Paediatr*. [Review / Meta-Analysis]
Viberti B (2026). [PMID: 41604462](https://pubmed.ncbi.nlm.nih.gov/41604462/). *Sci Transl Med*. [Basic Science / Preclinical]
Ribeiro AC (2026). [PMID: 40554621](https://pubmed.ncbi.nlm.nih.gov/40554621/). *The Journal of clinical endocrinology and metabolism*. [Basic Science / Preclinical]
Chen X (2026). [PMID: 41578548](https://pubmed.ncbi.nlm.nih.gov/41578548/). *Medicine*. [Review / Meta-Analysis]
Huang H (2026). [PMID: 41380994](https://pubmed.ncbi.nlm.nih.gov/41380994/). *J Glob Antimicrob Resist*. [Basic Science / Preclinical]
Peters C (2026). [PMID: 42048107](https://pubmed.ncbi.nlm.nih.gov/42048107/). *Eur Thyroid J*. [Epidemiology / Natural History]
Shi L (2026). [PMID: 42087875](https://pubmed.ncbi.nlm.nih.gov/42087875/). *Front Endocrinol (Lausanne)*. [Review / Meta-Analysis]
Yeşilyurt M (2026). [PMID: 41808609](https://pubmed.ncbi.nlm.nih.gov/41808609/). *Veterinary medicine and science*. [Diagnostic / Biomarker]
Peteláková M (2026). [PMID: 41520761](https://pubmed.ncbi.nlm.nih.gov/41520761/). *Eur J Pharmacol*. [Basic Science / Preclinical]
Berry A (2026). [PMID: 41711372](https://pubmed.ncbi.nlm.nih.gov/41711372/). *Aust Vet J*. [Basic Science / Preclinical]